{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:48:38Z","timestamp":1783619318135,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2022R1A2C1010808"],"award-info":[{"award-number":["NRF-2022R1A2C1010808"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalofhospitalinfection.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jhin.2024.07.019","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:23:13Z","timestamp":1726244593000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Epidemiologic characteristics and risk factors of Clostridioides difficile infection in patients with active tuberculosis in the Republic of Korea: a nationwide population-based study"],"prefix":"10.1016","volume":"154","author":[{"given":"J.W.","family":"Suh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.J.","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.G.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.K.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2024.07.019_bib1","series-title":"Antibiotic resistance threats in the United States, 2019","year":"2019"},{"key":"10.1016\/j.jhin.2024.07.019_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12879-023-08096-0","article-title":"The burden of CDI in the United States: a multifactorial challenge","volume":"23","author":"Feuerstadt","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhin.2024.07.019_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12879-021-06147-y","article-title":"Burden of Clostridioides difficile infection (CDI) \u2013 a systematic review of the epidemiology of primary and recurrent CDI","volume":"21","author":"Finn","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhin.2024.07.019_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","article-title":"Risk factors for Clostridium difficile infection","volume":"10","author":"Bignardi","year":"1998","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2024.07.019_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/ice.2014.39","article-title":"Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: a systematic review and meta-analysis","volume":"36","author":"Furuya-Kanamori","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2024.07.019_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40168-016-0156-3","article-title":"Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection","volume":"4","author":"Vincent","year":"2016","journal-title":"Microbiome"},{"key":"10.1016\/j.jhin.2024.07.019_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000889","article-title":"Epidemiology and outcomes of Clostridium difficile infection among hospitalised patients: results of a multicentre retrospective study in South Africa","volume":"3","author":"Legenza","year":"2018","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.jhin.2024.07.019_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3904\/kjim.2004.19.4.261","article-title":"A\u00a0case of pseudomembranous colitis associated with rifampin","volume":"19","author":"Park","year":"2004","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jhin.2024.07.019_bib9","first-page":"44","article-title":"A\u00a0case of pseudomembranous colitis associated with antituberculosis therapy in a patient with tuberculous meningitis","volume":"15","author":"Kim","year":"2014","journal-title":"J\u00a0Biomed Res"},{"key":"10.1016\/j.jhin.2024.07.019_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MCG.0b013e31802dfaf7","article-title":"Clinical aspects of rifampicin-associated pseudomembranous colitis","volume":"41","author":"Jung","year":"2007","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhin.2024.07.019_bib11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2169\/internalmedicine.52.0162","article-title":"Clostridium difficile infection associated with antituberculous agents in a patient with tuberculous pericarditis","volume":"52","author":"Sun","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.jhin.2024.07.019_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAJ.0b013e31819f1eec","article-title":"Rifampin-associated pseudomembranous colitis","volume":"338","author":"Chen","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jhin.2024.07.019_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5946\/ce.2011.44.2.137","article-title":"Rifampin-induced pseudomembranous colitis with rectosigmoid sparing","volume":"44","author":"Yim","year":"2011","journal-title":"Clin Endosc"},{"key":"10.1016\/j.jhin.2024.07.019_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4046\/trd.2022.0111","article-title":"Tuberculosis: Republic of Korea, 2021","volume":"86","author":"Min","year":"2023","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.jhin.2024.07.019_bib15","first-page":"578","article-title":"Global burden of tuberculosis in 2021","volume":"16","author":"Lee","year":"2023","journal-title":"Publ Health Wkly Rep"},{"key":"10.1016\/j.jhin.2024.07.019_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5009\/gnl14435","article-title":"Incidence and clinical outcomes of Clostridium difficile infection after treatment with tuberculosis medication","volume":"10","author":"Lee","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhin.2024.07.019_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.puhe.2022.12.009","article-title":"Impact of tuberculosis on the incidence of osteoporosis and osteoporotic fractures: a nationwide population-based cohort study","volume":"216","author":"Park","year":"2023","journal-title":"Public Health"},{"key":"10.1016\/j.jhin.2024.07.019_bib18","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2024.07.019_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.11604\/pamj.2015.22.253.6576","article-title":"Determinants of death among tuberculosis patients in a semi urban diagnostic and treatment centre of Bafoussam, West Cameroon: a retrospective case\u2013control study","volume":"22","author":"Djouma","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jhin.2024.07.019_bib20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1183\/09031936.00131107","article-title":"Risk factors for death among tuberculosis cases: analysis of European surveillance data","volume":"31","author":"Lefebvre","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhin.2024.07.019_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac512","article-title":"Effect of gender on clinical presentation of tuberculosis (TB) and age-specific risk of TB, and TB-human immunodeficiency virus coinfection","volume":"9","author":"Humayun","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhin.2024.07.019_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.09.044","article-title":"Challenges in the management of patients with TB and Clostridium difficile","volume":"158","author":"Popescu-Hagen","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jhin.2024.07.019_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO\u2019s global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jhin.2024.07.019_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.17597","article-title":"Incidence and outcomes associated with Clostridium difficile infections: a systematic review and meta-analysis","volume":"3","author":"Marra","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jhin.2024.07.019_bib25","series-title":"Healthcare-associated infections\u2013community interface surveillance report, Clostridioides difficile infection (CDI), 2020","year":"2020"},{"key":"10.1016\/j.jhin.2024.07.019_bib26","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.3346\/jkms.2020.35.e407","article-title":"Association between antibiotic consumption and incidence of Clostridioides difficile infection in a hospital","volume":"35","author":"Kim","year":"2020","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jhin.2024.07.019_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/510386","article-title":"The epidemiology and economic burden of Clostridium difficile infection in Korea","volume":"2015","author":"Choi","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhin.2024.07.019_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S0950268812000581","article-title":"Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study","volume":"141","author":"Kim","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jhin.2024.07.019_bib29","first-page":"265","article-title":"Clostridium difficile infection","volume":"10","author":"Shin","year":"2016","journal-title":"Emerg Infect"},{"key":"10.1016\/j.jhin.2024.07.019_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/pathogens11101101","article-title":"Tuberculosis in an aging world","volume":"11","author":"Olmo-Font\u00e1nez","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.jhin.2024.07.019_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1253615","article-title":"The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study","volume":"11","author":"Nowi\u0144ski","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.jhin.2024.07.019_bib32","article-title":"Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression","volume":"9","author":"C\u00e1ceres","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.jhin.2024.07.019_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13756-021-00986-9","article-title":"Correlation between antibiotic consumption and the incidence of healthcare facility-onset Clostridioides difficile infection: a retrospective chart review and analysis","volume":"10","author":"Yun","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jhin.2024.07.019_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fpubh.2020.00293","article-title":"Risk factors for primary Clostridium difficile infection; results from the Observational Study of Risk Factors for Clostridium difficile Infection in Hospitalized Patients With Infective Diarrhea (ORCHID)","volume":"8","author":"Davies","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.jhin.2024.07.019_bib35","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jac\/dkr508","article-title":"Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics","volume":"67","author":"Hensgens","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2024.07.019_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.idc.2017.07.003","article-title":"Clostridium difficile in older adults","volume":"31","author":"Donskey","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhin.2024.07.019_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.1260","article-title":"Impact of antibiotics on the human microbiome and consequences for host health","volume":"11","author":"Patangia","year":"2022","journal-title":"Microbiologyopen"},{"key":"10.1016\/j.jhin.2024.07.019_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10096-013-1845-5","article-title":"Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland","volume":"32","author":"Obuch-Woszczaty\u0144ski","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2024.07.019_bib39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2024.07.019_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.102106","article-title":"A\u00a0nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea","volume":"60","author":"Byun","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.jhin.2024.07.019_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174716","article-title":"Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals","volume":"12","author":"Nicholas","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2024.07.019_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3947\/ic.2022.0027","article-title":"Which is the preferred regimen for non-severe Clostridioides difficile infection in Korea, vancomycin or metronidazole?","volume":"54","author":"Kim","year":"2022","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jhin.2024.07.019_bib43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5009\/gnl.2010.4.3.332","article-title":"Risk factors for treatment failure and recurrence after metronidazole treatment for Clostridium difficile-associated diarrhea","volume":"4","author":"Jung","year":"2010","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhin.2024.07.019_bib44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhin.2024.07.019_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5009\/gnl18071","article-title":"Recurrent Clostridium difficile infection: risk factors, treatment, and prevention","volume":"13","author":"Song","year":"2019","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhin.2024.07.019_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2047-2994-1-20","article-title":"Mortality and Clostridium difficile infection: a review","volume":"1","author":"Mitchell","year":"2012","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jhin.2024.07.019_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/antibiotics10030299","article-title":"Mortality following Clostridioides difficile infection in Europe: a retrospective multicenter case\u2013control study","volume":"10","author":"Czepiel","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jhin.2024.07.019_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2012.05.008","article-title":"Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review","volume":"82","author":"Bloomfield","year":"2012","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2024.07.019_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098400","article-title":"Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review","volume":"9","author":"Abou Chakra","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670124002998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670124002998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:44:47Z","timestamp":1732409087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670124002998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"alternative-id":["S0195670124002998"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2024.07.019","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiologic characteristics and risk factors of Clostridioides difficile infection in patients with active tuberculosis in the Republic of Korea: a nationwide population-based study","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2024.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Healthcare Infection Society. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}